Clindamycin

Clindamycin is a lincosamide antibiotic that inhibits bacterial protein synthesis at the 50S ribosomal subunit. It is effective against anaerobic bacteria and certain gram-positive organisms. It is used for skin and soft tissue infections, dental infections, bone and joint infections, and as an alternative for penicillin-allergic patients. Mediocon Inc supplies pharmaceutical-grade Clindamycin meeting IP/BP/EP/USP standards.

Key Features

• Lincosamide antibiotic – excellent anaerobic coverage
• IP/BP/EP/USP compliant, Assay 99.0% Min.
• Effective for MRSA-associated skin infections
• Suitable for oral capsule, topical, and IV formulations

Applications

• Skin and soft tissue infection treatment
• Dental abscess and oral infection therapy
• Bone and joint infection treatment
• Acne topical gel and solution formulations

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings